ORLANDO, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and non-infectious diseases, today announced that it has retained Maxim Group LLC, a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services to the company. Maxim will focus on strategies to maximize shareholder value through its full scope of investment banking services.
“Engaging Maxim is paramount in the company's maturation that will enable the strategic positioning of Immune Therapeutics for investors and, in turn, increase its capacity to reach as many people who will benefit from its proprietary immune therapy,” said Immune Therapeutics Chief Executive Officer, Noreen Griffin.
Ritesh Veera, Managing Director of Maxim Group, commented, "We are delighted to partner with Immune Therapeutics, Inc. in the financial and value creation components of its corporate strategy through our full-service investment banking capabilities. We are looking forward to working with Immune Therapeutics to assist with strategic planning, developing strategic partnerships, advising on potential acquisitions and introducing the company to the investment community."
About Maxim Group LLC
Maxim Group LLC is a leading full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed income and derivative sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA), Securities Insurance Protection Corporation (SIPC), NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visitwww.maximgrp.com.
About Immune Therapeutics, Inc.
Immune Therapeutics, Inc. [F/K/A TNI Biotech, Inc.] is a biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy. Its products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.
